A multi-center, double-blind, placebo-controlled study designed to determine whether administration of recombinant human erythropoietin to premature infants will stimulate endogenous erythropoiesis sufficiently to stabilize or increase the hematocrit.
Showing the most recent 10 out of 381 publications